VLN Commercial Launches Confirm Viability of the FDA’s Proposed Reduced Nicotine Mandate

Core Viewpoint - 22nd Century Group is leading the initiative to reduce smoking rates and health harms through the adoption of its VLN reduced nicotine content products, which contain 95% less nicotine than conventional cigarettes [1][3][8] Group 1: Product and Technology - VLN products are manufactured in the USA and are the only combustible cigarette products authorized by the FDA to meet the proposed nicotine standard of 0.7 mg per gram, averaging 0.5 mg per gram [3][5] - The proprietary technology used in VLN products allows for the regulation of nicotine biosynthesis in tobacco plants, resulting in high yield and full flavor with significantly reduced nicotine content [9] Group 2: Market and Regulatory Context - The recent partnerships with brands like Smoker Friendly VLN and Pinnacle VLN indicate a growing commitment among tobacco brands to comply with the FDA's proposed Tobacco Product Standard for Nicotine Yield [2][3] - The FDA's proposed standard aims to curb smoking-related harms and is expected to prevent approximately 48 million youth and young adults from initiating smoking by the year 2100 [4][6] Group 3: Company Strategy and Vision - The company is actively monitoring the comment submissions regarding the proposed rule and plans to submit its own feedback, reflecting its commitment to influence regulatory outcomes [5] - The CEO of 22nd Century Group emphasized that the commercial launches of VLN products will enhance market availability and provide consumers with choices to control their nicotine consumption [3][4]